Advisor Group Holdings, Inc. Adaptive Biotechnologies Corp Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 69,914 shares of ADPT stock, worth $690,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,914
Previous 57,453 21.69%
Holding current value
$690,051
Previous $344,000 50.87%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$6.07 - $8.66 $75,638 - $107,912
12,461 Added 21.69%
69,914 $519,000
Q4 2024

Jun 06, 2025
SELL
$4.37 - $6.78 $43,367 - $67,284
-9,924 Reduced 14.19%
59,990 $359,000
Q3 2024

Nov 13, 2024
BUY
$3.37 - $5.12 $1,516 - $2,304
450 Added 0.79%
57,453 $294,000
Q2 2024

Aug 13, 2024
BUY
$2.34 - $3.96 $5,878 - $9,947
2,512 Added 4.61%
57,003 $206,000
Q1 2024

May 10, 2024
SELL
$2.88 - $4.8 $3,784 - $6,307
-1,314 Reduced 2.35%
54,491 $174,000
Q4 2023

Feb 12, 2024
SELL
$3.46 - $5.33 $195,981 - $301,901
-56,642 Reduced 50.37%
55,805 $273,000
Q3 2023

Nov 13, 2023
BUY
$5.07 - $8.44 $477,112 - $794,246
94,105 Added 513.06%
112,447 $612,000
Q2 2023

Aug 10, 2023
SELL
$6.19 - $8.78 $206,820 - $293,357
-33,412 Reduced 64.56%
18,342 $123,000
Q1 2023

May 12, 2023
BUY
$7.8 - $10.11 $23,212 - $30,087
2,976 Added 6.1%
51,754 $456,000
Q4 2022

Feb 10, 2023
SELL
$6.26 - $9.34 $15,324 - $22,864
-2,448 Reduced 4.78%
48,778 $372,000
Q3 2022

Nov 14, 2022
SELL
$6.5 - $12.67 $25,428 - $49,565
-3,912 Reduced 7.09%
51,226 $365,000
Q2 2022

Aug 10, 2022
BUY
$6.4 - $14.73 $29,894 - $68,803
4,671 Added 9.26%
55,138 $446,000
Q1 2022

May 04, 2022
SELL
$10.12 - $28.9 $18,560 - $53,002
-1,834 Reduced 3.51%
50,467 $699,000
Q3 2021

Nov 05, 2021
SELL
$30.02 - $39.87 $1,080 - $1,435
-36 Reduced 0.07%
52,301 $1.78 Million
Q2 2021

Aug 02, 2021
BUY
$32.22 - $44.59 $225,636 - $312,263
7,003 Added 15.45%
52,337 $2.14 Million
Q1 2021

May 13, 2021
BUY
$37.26 - $67.74 $101,570 - $184,659
2,726 Added 6.4%
45,334 $1.83 Million
Q4 2020

Feb 10, 2021
SELL
$45.01 - $65.47 $382,900 - $556,953
-8,507 Reduced 16.64%
42,608 $2.52 Million
Q3 2020

Nov 12, 2020
BUY
$35.79 - $48.81 $87,506 - $119,340
2,445 Added 5.02%
51,115 $2.48 Million
Q2 2020

Aug 14, 2020
SELL
$24.95 - $48.38 $3.37 Million - $6.54 Million
-135,110 Reduced 73.52%
48,670 $2.35 Million
Q1 2020

May 18, 2020
BUY
$16.96 - $34.16 $3.12 Million - $6.28 Million
183,780 New
183,780 $5.11 Million

Others Institutions Holding ADPT

# of Institutions
246
Shares Held
156M
Call Options Held
44.3K
Put Options Held
47.8K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.41B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email